Joni Doherty
Otolaryngology · Los Angeles, CANPI 1497786628
Payments from drug & device makers
Across 55 payments — averaging $297.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$9K
- Alcon Research LLC$4K
- Medtronic$1K
- Intersect ENT, Inc.$783
- Cochlear Americas$559
- Oticon Medical, LLC$250
- plus $822 from 6 others
What the payments were for
- Consulting fees$11,70071%
- Travel & lodging$1,0126%
- Food & beverage$3,64322%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 5 | $8,898 |
| Alcon Research LLC | 3 | $3,900 |
| Medtronic(2 entities) | 11 | $1,154 |
| Intersect ENT, Inc. | 11 | $783 |
| Cochlear Americas | 9 | $559 |
| Oticon Medical, LLC | 2 | $250 |
| Med-el Corporation | 4 | $249 |
| Iotamotion, Inc. | 2 | $245 |
| Grace Medical, Inc. | 1 | $245 |
| Integra Lifesciences Corporation | 1 | $38 |
| Boston Scientific | 1 | $33 |
| Travere Therapeutics, Inc. | 5 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NGENUITY$8,321
- Constellation$8,321
- PROPEL$981
- Baha$241
- iotaSOFT$176
- PONTO BONE ANCHORED HEARING SYSTEM$173
- NUVENT$143
- FUSION$125
- Nucleus$121
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$120
- OSIA OSI300 IMPLANT$120
- NIM Vital$112
- i7$101
How this compares
$16,367 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 13 | $974 |
| Fluticasone Propionate | 31 | $589 |
| Acetazolamide | 11 | $558 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Los Angeles
- Keith BlackwellLos Angeles$349K
- Martin HoppLos Angeles$321K
- Arthur WuLos Angeles$279K
- Dennis TangLos Angeles$261K
- Jeffrey SuhLos Angeles$228K
- Kevin ChoiLos Angeles$190K
- Elisabeth FerenceLos Angeles$124K
- Gene LiuLos Angeles$84K
- Robert KangLos Angeles$57K
- Richard MichelinLos Angeles$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.